Table 3.
Sex | |||||
---|---|---|---|---|---|
Female | Male | Total | |||
Diagnosis | NO FASD | n | 34 | 47 | 81 |
% diagnosis | 42.0% | 58.0% | 100.0% | ||
% by gender | 55.7% | 46.5% | 50.0% | ||
% total | 21.0% | 29.0% | 50.0% | ||
ARBD | n | 2 | 0 | 2 | |
% diagnosis | 100.0% | 0.0% | 100.0% | ||
% by gender | 3.3% | 0.0% | 1.2% | ||
% total | 1.2% | 0.0% | 1.2% | ||
ARND | n | 5 | 13 | 18 | |
% diagnosis | 27.8% | 72.2% | 100.0% | ||
% by gender | 8.2% | 12.9% | 11.1% | ||
% total | 3.1% | 8.0% | 11.1% | ||
FAS | n | 12 | 21 | 33 | |
% diagnosis | 36.4% | 63,6% | 100.0% | ||
% by gender | 19.7% | 20.8% | 20.4% | ||
% total | 7.4% | 13.0% | 20.4% | ||
pFAS | n | 8 | 20 | 28 | |
% diagnosis | 28.6% | 71.4% | 100.0% | ||
% by gender | 13.1% | 19.8% | 17.3% | ||
% total | 4.9% | 12.3% | 17.3% | ||
TOTAL | n | 61 | 101 | 162 | |
% diagnosis | 37.7% | 62.3% | 100.0% | ||
% by gender | 100.0% | 100.0% | 100.0% | ||
% total | 37.7% | 62.3% | 100.0% |